In addition, recent evidence suggests that circulating IL-33 may confer protective metabolic effects (body mass index (BMI), lipid profile, and glycated hemoglobin (HbA1c)) in humans, specifically, in individuals with normal weight and glycemia but not in those with obesity and/or T2D [54]. The gene discussed is IL33; the disease is obesity due to melanocortin 4 receptor deficiency.